Found 112 matching trials
Efficacy and Safety of Risedronate Therapy Administered 35 mg Once A Week in Men With Osteoporosis PHASE3 Two year study to determine the safety and efficacy of weekly 35 mg Risedro...
Show More Learn More & Join Trial
Effect of Stopping Risedronate After Long Term Treatment on Bone Turnover PHASE3 The effects of stopping long-term (7 years) and short term (2 years) risedr...
Show More Location
Investigational Site
Learn More & Join Trial
Replication of the VERO Osteoporosis Trial in Healthcare Claims Data N/A Investigators are building an empirical evidence base for real world data t...
Show More Location
Brigham and Women's Hospital
Learn More & Join Trial
Resolution of Effect of Bisphosphonates on Bone in Postmenopausal Osteoporosis N/A This is a 2year observational study that will recruit patients who have pre...
Show More Location
Sheffield Teaching Hospitals NHS Foundation Trust
Learn More & Join Trial
Satisfaction and Compliance of Risedronate in PMO PHASE4 Compare subject satisfaction of once a week dosing of 35 mg Risedronate to ...
Show More Learn More & Join Trial
Risedronate in Postmenopausal Women With Low Bone Density PHASE2 The primary objective of this pilot study is to estimate the percent change...
Show More Location
Multiple Locations
Learn More & Join Trial
Short-term Functional Recovery Between Early- and Late Bisphosphonate Treatment Following Hemiarthroplasty PHASE4 Femoral neck fracture in the elderly is one indication for initiating osteo...
Show More Learn More & Join Trial
Impact of Vertebral Fracture Knowledge on Persistence in Subjects Taking Glucocorticoid Therapy PHASE4 To evaluate the effect of subject knowledge of their disease status on pers...
Show More Learn More & Join Trial
Risedronate Therapy in the Treatment of Low Bone Mineral Density in Crohn's Disease PHASE4 The occurrence of bone loss in Crohn's disease patients is an important cli...
Show More Location
Gastrointestinal and Liver Disease Research (GILDR) Group
Learn More & Join Trial
VERtebral Fracture Treatment Comparisons in Osteoporotic Women PHASE4 The primary purpose of participation in this study is to answer whether ter...
Show More Location
For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician.
Learn More & Join Trial